Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans
Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well...
Saved in:
Published in | Journal of molecular medicine (Berlin, Germany) Vol. 87; no. 8; pp. 803 - 813 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.08.2009
Springer Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0946-2716 1432-1440 |
DOI | 10.1007/s00109-009-0486-8 |
Cover
Loading…
Abstract | Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (
p
< 0.0001) and protein (
p
= 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (
p
= 0.038) in the obese group. Moreover, obese individuals showed increased (
p
< 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (
p
< 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (
p
< 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity. |
---|---|
AbstractList | Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (p < 0.0001) and protein (p = 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (p = 0.038) in the obese group. Moreover, obese individuals showed increased (p < 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (p < 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (p < 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity. Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA (p<0.0001) and protein (p=0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found (p=0.038) in the obese group. Moreover, obese individuals showed increased (p<0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation (p<0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers (p<0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity.[PUBLICATION ABSTRACT] Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the effect of obesity on circulating concentrations and gene and protein expression levels of LCN2 in human visceral adipose tissue (VAT) as well as its involvement in inflammation. VAT biopsies from 47 subjects were used in the study. Real-time PCR and Western-blot analyses were performed to quantify levels of LCN2 in VAT as well as the association with other genes implicated in inflammatory pathways. Forty-four serum samples were used to analyze the circulating concentrations of LCN2. Zymography analysis was used to determine the activity of matrix metalloproteinase (MMP) in VAT. Obese patients exhibited increased mRNA ( p < 0.0001) and protein ( p = 0.017) expression levels of LCN2 compared to lean subjects. Although no differences in plasma LCN2 concentrations were observed, increased circulating LCN2/MMP-9 complex levels were found ( p = 0.038) in the obese group. Moreover, obese individuals showed increased ( p < 0.01) activity of MMP-2 and MMP-9/LCN2 complex, while a positive correlation ( p < 0.01) between MMP-2 and MMP-9 activities and BMI was observed. Gene and protein expression levels of LCN2 in VAT were positively associated with inflammatory markers ( p < 0.01). These findings represent the first observation that mRNA and protein levels of LCN2 are increased in human VAT of obese subjects. Furthermore, LCN2 is associated with MMP-2 and MMP-9 activities as well as with pro-inflammatory markers suggesting its potential involvement in the low-grade chronic inflammation accompanying obesity. |
Author | Catalán, V. Ramírez, B. Silva, C. Rotellar, F. Cienfuegos, J. A. Gil, M. J. Salvador, J. Gómez-Ambrosi, J. Rodríguez, A. Frühbeck, G. |
Author_xml | – sequence: 1 givenname: V. surname: Catalán fullname: Catalán, V. organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 2 givenname: J. surname: Gómez-Ambrosi fullname: Gómez-Ambrosi, J. organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 3 givenname: A. surname: Rodríguez fullname: Rodríguez, A. organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 4 givenname: B. surname: Ramírez fullname: Ramírez, B. organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 5 givenname: C. surname: Silva fullname: Silva, C. organization: Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 6 givenname: F. surname: Rotellar fullname: Rotellar, F. organization: Department of Surgery, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 7 givenname: M. J. surname: Gil fullname: Gil, M. J. organization: Department of Biochemistry, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 8 givenname: J. A. surname: Cienfuegos fullname: Cienfuegos, J. A. organization: Department of Surgery, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 9 givenname: J. surname: Salvador fullname: Salvador, J. organization: Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición – sequence: 10 givenname: G. surname: Frühbeck fullname: Frühbeck, G. email: gfruhbeck@unav.es organization: Metabolic Research Laboratory, Clínica Universitaria de Navarra, University of Navarra, Department of Endocrinology, Clínica Universitaria de Navarra, University of Navarra, CIBER Fisiopatología de la Obesidad y Nutrición |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21766997$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19466389$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkstu1TAQhi1URC_wAGyQhQS7gJ04drxEFZdKldjA2nKcCbhy7IPHQe378KA4PYciFQELy9bM98_FM6fkKKYIhDzl7BVnTL1GxjjTDduOGGQzPCAnXHRtw4VgR-SEaSGbVnF5TE4Rryqtei0ekWNeHbIb9An5cRFdBoswUTv5XUKgxSOuQOF6lwHRp0jTTEP1ORt8bFrqq2UE9OWGeqQZgi1VXlJ1zMEuiy2byMaJ1mf213SBYkNIu5wK-FiT1SC37j_smlpX_HdfPOCW5-u62IiPycPZBoQnh_uMfH739tP5h-by4_uL8zeXjRNalsaOvXNtJ50eeuBu7PSk1cy61nZM9TCNjsGkRhhhsKPrpWSd7h0Ip6d5mjl0Z-TlPm6t6NsKWMzi0UEINkJa0UglZP04_l-wZVxI1rIKPr8HXqU1x9qEabmSgxCyq9CzA7SOC0xml_1i8435NaUKvDgAFusQ5myj83jHbZGk1qpyas-5nBAzzMb5cjuNkq0PhjOz7Y3Z741h26l7Y4aq5PeUd0X8Q9PuNVjZ-AXy797-LvoJ4U_YQg |
CitedBy_id | crossref_primary_10_1017_S095442241400002X crossref_primary_10_26508_lsa_202302228 crossref_primary_10_1016_j_biopha_2022_112879 crossref_primary_10_1152_ajpendo_00297_2015 crossref_primary_10_1210_en_2011_1642 crossref_primary_10_1016_j_molmet_2013_04_003 crossref_primary_10_1159_000337604 crossref_primary_10_3390_cancers14071679 crossref_primary_10_1177_1099800411410870 crossref_primary_10_1111_obr_12377 crossref_primary_10_1002_oby_22254 crossref_primary_10_1038_s41467_021_27734_2 crossref_primary_10_1016_j_diabres_2014_01_014 crossref_primary_10_1093_carcin_bgw050 crossref_primary_10_3390_ijms221910460 crossref_primary_10_1016_j_plipres_2010_10_005 crossref_primary_10_3390_ijerph182413333 crossref_primary_10_3389_fimmu_2022_935275 crossref_primary_10_1016_j_cyto_2011_07_021 crossref_primary_10_3390_jcm8060854 crossref_primary_10_1080_14737159_2023_2215928 crossref_primary_10_1074_jbc_M115_685644 crossref_primary_10_3389_fcvm_2020_583175 crossref_primary_10_1016_j_biochi_2022_09_003 crossref_primary_10_3390_metabo11020070 crossref_primary_10_1039_C7MT00241F crossref_primary_10_1016_j_metabol_2023_155527 crossref_primary_10_1016_j_peptides_2019_170117 crossref_primary_10_1007_s11695_013_1111_z crossref_primary_10_1007_s00592_012_0399_9 crossref_primary_10_1152_physiol_00037_2018 crossref_primary_10_1016_j_molmet_2023_101763 crossref_primary_10_1186_1471_230X_13_120 crossref_primary_10_1530_JOE_18_0314 crossref_primary_10_1002_biof_1628 crossref_primary_10_1002_oby_20507 crossref_primary_10_1038_s41598_020_71109_4 crossref_primary_10_1016_j_mce_2019_04_002 crossref_primary_10_1210_endocr_bqaa149 crossref_primary_10_1089_ten_tea_2017_0384 crossref_primary_10_1172_jci_insight_122289 crossref_primary_10_1111_j_1476_5381_2011_01528_x crossref_primary_10_3390_ijms17122125 crossref_primary_10_1055_a_1849_6707 crossref_primary_10_1371_journal_pone_0098398 crossref_primary_10_1155_2013_204164 crossref_primary_10_3390_nu14235049 crossref_primary_10_1007_s00266_021_02649_x crossref_primary_10_1096_fj_201600787rr crossref_primary_10_2174_1874288201812010089 crossref_primary_10_1016_j_mce_2016_03_011 crossref_primary_10_21518_2079_701X_2022_16_6_264_272 crossref_primary_10_1155_2011_587495 crossref_primary_10_1186_1476_9255_9_35 crossref_primary_10_1055_a_1909_1922 crossref_primary_10_3390_jcm9041069 crossref_primary_10_1016_j_jnutbio_2010_04_015 crossref_primary_10_1016_j_pharma_2012_10_003 crossref_primary_10_1016_j_jdermsci_2020_06_008 crossref_primary_10_1016_j_endmts_2020_100061 crossref_primary_10_1038_oby_2011_61 crossref_primary_10_3390_rheumato4040016 crossref_primary_10_1007_s13105_016_0547_8 crossref_primary_10_1016_j_pan_2020_01_002 crossref_primary_10_1007_s12263_013_0380_4 crossref_primary_10_1530_EJE_11_0660 crossref_primary_10_1038_nrrheum_2011_107 crossref_primary_10_1186_s12944_022_01622_0 crossref_primary_10_1007_s11695_014_1407_7 crossref_primary_10_1016_j_jff_2016_06_026 crossref_primary_10_1016_j_clinre_2024_102336 crossref_primary_10_1152_physiolgenomics_00039_2012 crossref_primary_10_3389_fendo_2018_00167 crossref_primary_10_3390_ijms19113331 crossref_primary_10_1038_s41537_019_0075_y crossref_primary_10_3109_10715762_2015_1134795 crossref_primary_10_3109_14767058_2010_487138 crossref_primary_10_3389_fonc_2020_605097 crossref_primary_10_1631_jzus_B1600383 crossref_primary_10_1007_s11357_021_00322_4 crossref_primary_10_1155_2017_9039302 crossref_primary_10_1210_endocr_bqz010 crossref_primary_10_1038_s41392_023_01376_w crossref_primary_10_2147_DMSO_S338254 crossref_primary_10_1007_s00394_012_0464_8 crossref_primary_10_1161_HYPERTENSIONAHA_115_05431 crossref_primary_10_1016_j_pneurobio_2015_06_005 crossref_primary_10_1152_ajpheart_00907_2011 crossref_primary_10_3390_nu12051305 crossref_primary_10_2337_dc11_s238 crossref_primary_10_1016_j_nut_2015_01_009 crossref_primary_10_1096_fj_202101105R crossref_primary_10_3390_biom11070921 crossref_primary_10_1016_j_gene_2024_148766 crossref_primary_10_1097_MD_0000000000004039 crossref_primary_10_7570_kjo_2014_23_4_222 crossref_primary_10_1016_j_jss_2012_05_008 crossref_primary_10_1016_j_arr_2021_101414 crossref_primary_10_1021_bi201115q crossref_primary_10_1016_j_atherosclerosis_2018_06_015 crossref_primary_10_1136_ard_2010_132399 crossref_primary_10_1007_s11695_019_03914_4 crossref_primary_10_1111_j_1440_1681_2011_05557_x crossref_primary_10_1155_2010_784343 crossref_primary_10_1016_j_bcp_2019_113626 crossref_primary_10_1159_000444855 crossref_primary_10_18632_oncotarget_14589 crossref_primary_10_1016_j_canlet_2011_11_002 crossref_primary_10_1111_jgh_12597 crossref_primary_10_1016_j_jnutbio_2012_12_005 crossref_primary_10_1016_j_peptides_2017_03_001 crossref_primary_10_1111_bcpt_13332 crossref_primary_10_1074_jbc_M113_532234 crossref_primary_10_1111_eci_12649 crossref_primary_10_1371_journal_pone_0048612 crossref_primary_10_1007_s11010_016_2857_0 crossref_primary_10_1016_j_biochi_2012_12_014 crossref_primary_10_1158_0008_5472_CAN_16_1986 crossref_primary_10_1080_00207454_2017_1349766 crossref_primary_10_1074_jbc_M110_123331 crossref_primary_10_1111_j_1476_5381_2011_01587_x crossref_primary_10_3892_mmr_2024_13329 crossref_primary_10_1016_j_molmet_2019_09_009 crossref_primary_10_1038_ijo_2013_199 crossref_primary_10_1111_jdv_13701 crossref_primary_10_1016_S2468_1253_16_30106_6 crossref_primary_10_1186_s12974_024_03104_9 crossref_primary_10_2337_db09_1541 crossref_primary_10_1038_s41419_023_06160_w crossref_primary_10_1161_HYPERTENSIONAHA_111_187872 crossref_primary_10_1007_s00105_024_05306_x crossref_primary_10_2337_dc14_0937 crossref_primary_10_1146_annurev_nutr_071816_064559 crossref_primary_10_1080_08037051_2016_1249336 crossref_primary_10_1038_s41419_021_03512_2 crossref_primary_10_1007_s12263_015_0460_8 crossref_primary_10_2147_BCTT_S491277 crossref_primary_10_3390_ijms22062865 crossref_primary_10_1017_S0954422412000145 crossref_primary_10_1038_nri2921 crossref_primary_10_3390_ijms21155529 crossref_primary_10_1152_physiolgenomics_00118_2019 crossref_primary_10_1155_2019_8171373 crossref_primary_10_3390_ijms22041667 crossref_primary_10_4236_jdm_2011_14012 crossref_primary_10_1111_eci_12997 crossref_primary_10_1089_met_2024_0099 crossref_primary_10_1016_j_bbadis_2013_05_006 crossref_primary_10_1016_j_tem_2017_01_003 crossref_primary_10_1038_s41574_019_0246_y crossref_primary_10_1111_1346_8138_13227 |
Cites_doi | 10.2337/dc08-1236 10.1055/s-2002-38256 10.1097/01.hjh.0000239295.17636.6e 10.1038/oby.2005.146 10.1038/nature05488 10.1016/j.metabol.2008.02.019 10.1111/j.1467-789X.2007.00316.x 10.1161/01.RES.0000227550.00426.60 10.1096/fj.00-0829hyp 10.1210/me.2007-0420 10.1053/j.gastro.2007.03.059 10.1074/jbc.270.38.22565 10.1074/jbc.M107101200 10.2337/db07-0007 10.1111/j.1600-6143.2006.01723.x 10.1111/j.1365-2265.2007.03156.x 10.2337/diabetes.47.9.1384 10.1210/jc.2007-0349 10.1002/jcb.21980 10.1007/s11695-008-9424-z 10.1002/path.1400 10.1038/nature05487 10.1038/nature03104 10.2337/diabetes.50.9.2080 10.1126/science.7678183 10.1016/j.cmet.2007.04.006 10.1007/978-1-59745-245-8_1 10.1038/nature03711 10.1053/j.gastro.2007.03.058 10.1016/0014-5793(92)81511-J 10.1055/s-2007-982502 10.1074/jbc.M103334200 10.1126/science.1061075 10.1074/jbc.M106089200 10.2174/138161207781039599 10.1373/clinchem.2006.075614 10.1016/j.cell.2005.10.027 10.1016/j.tcb.2005.12.005 10.1016/j.febslet.2004.12.031 10.1093/ajcn/83.2.461S 10.1111/j.1365-2265.2007.03021.x 10.1038/bjc.1996.374 10.1007/s00125-003-1053-4 10.1096/fj.03-0591fje 10.1172/JCI23056 10.1160/TH07-10-0589 10.1152/ajpendo.2001.280.6.E827 |
ContentType | Journal Article |
Copyright | Springer-Verlag 2009 2009 INIST-CNRS |
Copyright_xml | – notice: Springer-Verlag 2009 – notice: 2009 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7TS 7X8 |
DOI | 10.1007/s00109-009-0486-8 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Physical Education Index MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) Physical Education Index MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Physical Education Index ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central (NC Live) url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-1440 |
EndPage | 813 |
ExternalDocumentID | 1966527461 19466389 21766997 10_1007_s00109_009_0486_8 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -4W -56 -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 2.D 203 28- 29L 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3O- 3SX 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67N 67Z 6NX 78A 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDZT ABECU ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABOCM ABPLI ABQBU ABQSL ABSXP ABTEG ABTHY ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACZOJ ADBBV ADHIR ADIMF ADINQ ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYPR ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFEXP AFGCZ AFKRA AFLOW AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AOCGG ARMRJ ASPBG AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BPHCQ BSONS BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 EPAXT ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GXS H13 HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SBY SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZN T13 T16 TSG TSK TSV TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK6 WK8 X7M YLTOR Z45 Z7R Z7U Z7W Z7Z Z82 Z83 Z87 Z8M Z8O Z8Q Z8T Z8V Z8W Z91 ZMTXR ZOVNA ~EX AAPKM AAYXX ABBRH ABDBE ADHKG AFDZB AFOHR AGQPQ AHPBZ ATHPR AYFIA CITATION PHGZM PHGZT ABRTQ IQODW PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7TK 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7TS PUEGO 7X8 |
ID | FETCH-LOGICAL-c496t-ab5cc236c985e1cb39d97f032a3075edbc0ed7bebe8abc5660395ce4c9dfdf1e3 |
IEDL.DBID | 7X7 |
ISSN | 0946-2716 |
IngestDate | Mon Jul 21 09:41:24 EDT 2025 Sun Aug 24 03:58:46 EDT 2025 Sat Aug 23 13:08:43 EDT 2025 Wed Feb 19 01:49:39 EST 2025 Mon Jul 21 09:11:59 EDT 2025 Thu Apr 24 23:06:08 EDT 2025 Tue Jul 01 02:55:26 EDT 2025 Fri Feb 21 02:25:55 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Obesity Visceral adipose tissue Inflammation Gene expression Lipocalin-2 Human Adipose tissue Enzyme Nutrition disorder Metalloendopeptidases Biological activity Gelatinase B Gelatinase A Medicine Peptidases Hydrolases Metalloproteinase Neutrophil gelatinase associated lipocalin Nutritional status Viscus |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c496t-ab5cc236c985e1cb39d97f032a3075edbc0ed7bebe8abc5660395ce4c9dfdf1e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 19466389 |
PQID | 217684463 |
PQPubID | 48876 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_67464661 proquest_miscellaneous_20146020 proquest_journals_217684463 pubmed_primary_19466389 pascalfrancis_primary_21766997 crossref_citationtrail_10_1007_s00109_009_0486_8 crossref_primary_10_1007_s00109_009_0486_8 springer_journals_10_1007_s00109_009_0486_8 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-08-01 |
PublicationDateYYYYMMDD | 2009-08-01 |
PublicationDate_xml | – month: 08 year: 2009 text: 2009-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Heidelberg – name: Germany – name: New York |
PublicationTitle | Journal of molecular medicine (Berlin, Germany) |
PublicationTitleAbbrev | J Mol Med |
PublicationTitleAlternate | J Mol Med (Berl) |
PublicationYear | 2009 |
Publisher | Springer-Verlag Springer Springer Nature B.V |
Publisher_xml | – name: Springer-Verlag – name: Springer – name: Springer Nature B.V |
References | Van Gaal, Mertens, De Block (CR5) 2006; 444 Gómez-Ambrosi, Catalán, Ramírez, Rodríguez, Colina, Silva, Rotellar, Mugueta, Gil, Cienfuegos (CR45) 2007; 92 Greenberg, Obin (CR21) 2006; 83 Zhang, Wu, Zhang, Leroith, Bernlohr, Chen (CR14) 2008; 22 Catalán, Gómez-Ambrosi, Rodríguez, Silva, Rotellar, Gil, Cienfuegos, Salvador, Frühbeck (CR29) 2008; 68 Lai, Seshadri, Huang, Shao, Cai, Vattikuti, Schumacher, Loewy, Denhardt, Rittling (CR43) 2006; 98 Frühbeck, Gómez-Ambrosi, Muruzábal, Burrell (CR32) 2001; 280 Mori, Lee, Rapoport, Drexler, Foster, Yang, Schmidt-Ott, Chen, Li, Weiss (CR47) 2005; 115 Yan, Borregaard, Kjeldsen, Moses (CR24) 2001; 276 Fain, Buehrer, Bahouth, Tichansky, Madan (CR33) 2008; 57 Trayhurn (CR4) 2007; 8 Aigner, Maier, Schwelberger, Wallnofer, Amberger, Obrist, Berger, Mak, Maglione, Margreiter (CR18) 2007; 7 Shoelson, Herrero, Naaz (CR20) 2007; 132 Tan, Adya, Shan, Syed, Lewandowski, O'Hare, Randeva (CR15) 2009; 32 Christiaens, Scroyen, Lijnen (CR41) 2008; 99 Lin, Rajala, Berger, Moller, Barzilai, Scherer (CR17) 2001; 276 Bouloumié, Sengenès, Portolan, Galitzky, Lafontan (CR23) 2001; 50 Ginde, Geliebter, Rubiano, Silva, Wang, Heshka, Heymsfield (CR25) 2005; 13 Wajchenberg, Giannella-Neto, da Silva, Santos (CR36) 2002; 34 Frühbeck (CR7) 2008; 456 Hotamisligil, Shargill, Spiegelman (CR46) 1993; 259 Yang, Graham, Mody, Preitner, Peroni, Zabolotny, Kotani, Quadro, Kahn (CR34) 2005; 436 Rangaswami, Bulbule, Kundu (CR42) 2006; 16 Badman, Flier (CR1) 2007; 132 Rodríguez, Frühbeck, Gómez-Ambrosi, Catalán, Sáinz, Diez, Zalba, Fortuño (CR30) 2006; 24 Philip, Bulbule, Kundu (CR44) 2001; 276 Liu, Nilsen-Hamilton (CR11) 1995; 270 Hvidberg, Jacobsen, Strong, Cowland, Moestrup, Borregaard (CR40) 2005; 579 Sier, Kubben, Ganesh, Heerding, Griffioen, Hanemaaijer, van Krieken, Lamers, Verspaget (CR31) 1996; 74 Flo, Smith, Sato, Rodriguez, Holmes, Strong, Akira, Aderem (CR8) 2004; 432 Sethi, Vidal-Puig (CR6) 2007; 5 Yan, Yang, Mody, Graham, Hsu, Xu, Houstis, Kahn, Rosen (CR13) 2007; 56 Frühbeck, Gómez-Ambrosi (CR3) 2003; 46 Sommer, Weise, Kralisch, Lossner, Bluher, Stumvoll, Fasshauer (CR19) 2009; 106 Catalán, Gómez-Ambrosi, Rotellar, Silva, Rodríguez, Salvador, Gil, Cienfuegos, Frühbeck (CR28) 2007; 39 Stamenkovic (CR22) 2003; 200 Devireddy, Teodoro, Richard, Green (CR16) 2001; 293 Wang, Lam, Kraegen, Sweeney, Zhang, Tso, Chow, Wat, Xu, Hoo (CR12) 2007; 53 Devireddy, Gazin, Zhu, Green (CR9) 2005; 123 Gómez-Ambrosi, Catalán, Diez-Caballero, Martínez-Cruz, Gil, García-Foncillas, Cienfuegos, Salvador, Mato, Frühbeck (CR27) 2004; 18 Després, Lemieux (CR37) 2006; 444 Gómez-Ambrosi, Rodríguez, Catalán, Ramírez, Silva, Rotellar, Gil, Salvador, Frühbeck (CR35) 2008; 69 Catalán, Gómez-Ambrosi, Ramírez, Rotellar, Pastor, Silva, Rodríguez, Gil, Cienfuegos, Frühbeck (CR26) 2007; 17 Rodríguez, Catalán, Gómez-Ambrosi, Frühbeck (CR39) 2007; 13 Frühbeck, Gómez-Ambrosi (CR2) 2001; 15 Triebel, Blaser, Reinke, Tschesche (CR10) 1992; 314 Montague, Prins, Sanders, Zhang, Sewter, Digby, Byrne, O'Rahilly (CR38) 1998; 47 S Philip (486_CR44) 2001; 276 A Rodríguez (486_CR39) 2007; 13 JP Després (486_CR37) 2006; 444 G Frühbeck (486_CR2) 2001; 15 CF Lai (486_CR43) 2006; 98 Q Yang (486_CR34) 2005; 436 TH Flo (486_CR8) 2004; 432 G Frühbeck (486_CR7) 2008; 456 J Gómez-Ambrosi (486_CR45) 2007; 92 I Stamenkovic (486_CR22) 2003; 200 LF Gaal Van (486_CR5) 2006; 444 LR Devireddy (486_CR16) 2001; 293 V Catalán (486_CR26) 2007; 17 A Rodríguez (486_CR30) 2006; 24 P Trayhurn (486_CR4) 2007; 8 Y Lin (486_CR17) 2001; 276 J Gómez-Ambrosi (486_CR35) 2008; 69 MK Badman (486_CR1) 2007; 132 A Bouloumié (486_CR23) 2001; 50 V Hvidberg (486_CR40) 2005; 579 LR Devireddy (486_CR9) 2005; 123 V Christiaens (486_CR41) 2008; 99 L Yan (486_CR24) 2001; 276 K Mori (486_CR47) 2005; 115 G Sommer (486_CR19) 2009; 106 AS Greenberg (486_CR21) 2006; 83 H Rangaswami (486_CR42) 2006; 16 G Frühbeck (486_CR3) 2003; 46 BK Tan (486_CR15) 2009; 32 Q Liu (486_CR11) 1995; 270 G Frühbeck (486_CR32) 2001; 280 BL Wajchenberg (486_CR36) 2002; 34 V Catalán (486_CR29) 2008; 68 S Triebel (486_CR10) 1992; 314 V Catalán (486_CR28) 2007; 39 CF Sier (486_CR31) 1996; 74 SR Ginde (486_CR25) 2005; 13 J Gómez-Ambrosi (486_CR27) 2004; 18 CT Montague (486_CR38) 1998; 47 QW Yan (486_CR13) 2007; 56 SE Shoelson (486_CR20) 2007; 132 Y Wang (486_CR12) 2007; 53 JN Fain (486_CR33) 2008; 57 GS Hotamisligil (486_CR46) 1993; 259 JK Sethi (486_CR6) 2007; 5 F Aigner (486_CR18) 2007; 7 J Zhang (486_CR14) 2008; 22 18278177 - Thromb Haemost. 2008 Feb;99(2):290-4 8695357 - Br J Cancer. 1996 Aug;74(3):413-7 17498506 - Gastroenterology. 2007 May;132(6):2103-15 11522674 - Diabetes. 2001 Sep;50(9):2080-6 17639021 - Diabetes. 2007 Oct;56(10 ):2533-40 16877962 - J Hypertens. 2006 Aug;24(8):1589-97 16076993 - Obes Res. 2005 Jul;13(7):1232-7 15711640 - J Clin Invest. 2005 Mar;115(3):610-21 17040956 - Clin Chem. 2007 Jan;53(1):34-41 18852336 - Diabetes Care. 2009 Jan;32(1):129-31 15670845 - FEBS Lett. 2005 Jan 31;579(3):773-7 15531878 - Nature. 2004 Dec 16;432(7019):917-21 14630696 - FASEB J. 2004 Jan;18(1):215-7 11532980 - FASEB J. 2001 Sep;15(11):1996-2006 16377569 - Cell. 2005 Dec 29;123(7):1293-305 18292240 - Mol Endocrinol. 2008 Jun;22(6):1416-26 11350765 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E827-47 17498510 - Gastroenterology. 2007 May;132(6):2169-80 19009554 - J Cell Biochem. 2009 Jan 1;106(1):103-8 7545679 - J Biol Chem. 1995 Sep 22;270(38):22565-70 17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4 17595250 - J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27 17627548 - Curr Pharm Des. 2007;13(21):2169-75 12845612 - J Pathol. 2003 Jul;200(4):448-64 17803693 - Clin Endocrinol (Oxf). 2008 Feb;68(2):213-9 11486009 - J Biol Chem. 2001 Oct 5;276(40):37258-65 7678183 - Science. 1993 Jan 1;259(5091):87-91 11564733 - J Biol Chem. 2001 Nov 30;276(48):44926-35 16470013 - Am J Clin Nutr. 2006 Feb;83(2):461S-465S 11486081 - Science. 2001 Aug 3;293(5531):829-34 16709900 - Circ Res. 2006 Jun 23;98(12):1479-89 17391123 - Am J Transplant. 2007 Apr;7(4):779-88 12627314 - Diabetologia. 2003 Feb;46(2):143-72 17167477 - Nature. 2006 Dec 14;444(7121):881-7 18555844 - Metabolism. 2008 Jul;57(7):1005-15 17167476 - Nature. 2006 Dec 14;444(7121):875-80 18516549 - Methods Mol Biol. 2008;456:1-22 16406521 - Trends Cell Biol. 2006 Feb;16(2):79-87 18219773 - Obes Surg. 2007 Nov;17(11):1464-74 12660870 - Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21 17488634 - Cell Metab. 2007 May;5(5):323-5 17611901 - Horm Metab Res. 2007 Jul;39(7):495-500 1281792 - FEBS Lett. 1992 Dec 21;314(3):386-8 18081728 - Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15 16034410 - Nature. 2005 Jul 21;436(7049):356-62 11546817 - J Biol Chem. 2001 Nov 9;276(45):42077-83 9726225 - Diabetes. 1998 Sep;47(9):1384-91 |
References_xml | – volume: 32 start-page: 129 year: 2009 end-page: 131 ident: CR15 article-title: Ex vivo and in vivo regulation of lipocalin-2, a novel adipokine, by insulin publication-title: Diabetes Care doi: 10.2337/dc08-1236 – volume: 34 start-page: 616 year: 2002 end-page: 621 ident: CR36 article-title: Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome publication-title: Horm Metab Res doi: 10.1055/s-2002-38256 – volume: 24 start-page: 1589 year: 2006 end-page: 1597 ident: CR30 article-title: The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats publication-title: J Hypertens doi: 10.1097/01.hjh.0000239295.17636.6e – volume: 13 start-page: 1232 year: 2005 end-page: 1237 ident: CR25 article-title: Air displacement plethysmography: validation in overweight and obese subjects publication-title: Obes Res doi: 10.1038/oby.2005.146 – volume: 444 start-page: 881 year: 2006 end-page: 887 ident: CR37 article-title: Abdominal obesity and metabolic syndrome publication-title: Nature doi: 10.1038/nature05488 – volume: 57 start-page: 1005 year: 2008 end-page: 1015 ident: CR33 article-title: Comparison of messenger RNA distribution for 60 proteins in fat cells vs the nonfat cells of human omental adipose tissue publication-title: Metabolism doi: 10.1016/j.metabol.2008.02.019 – volume: 8 start-page: 41 issue: Suppl 1 year: 2007 end-page: 44 ident: CR4 article-title: Adipocyte biology publication-title: Obes Rev doi: 10.1111/j.1467-789X.2007.00316.x – volume: 115 start-page: 610 year: 2005 end-page: 621 ident: CR47 article-title: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury publication-title: J Clin Invest – volume: 98 start-page: 1479 year: 2006 end-page: 1489 ident: CR43 article-title: An osteopontin-NADPH oxidase signaling cascade promotes pro-matrix metalloproteinase 9 activation in aortic mesenchymal cells publication-title: Circ Res doi: 10.1161/01.RES.0000227550.00426.60 – volume: 15 start-page: 1996 year: 2001 end-page: 2006 ident: CR2 article-title: Rationale for the existence of additional adipostatic hormones publication-title: FASEB J doi: 10.1096/fj.00-0829hyp – volume: 22 start-page: 1416 year: 2008 end-page: 1426 ident: CR14 article-title: The role of lipocalin 2 in the regulation of inflammation in adipocytes and Macrophages publication-title: Mol Endocrinol doi: 10.1210/me.2007-0420 – volume: 132 start-page: 2169 year: 2007 end-page: 2180 ident: CR20 article-title: Obesity, inflammation, and insulin resistance publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.059 – volume: 46 start-page: 143 year: 2003 end-page: 172 ident: CR3 article-title: Control of body weight: a physiologic and transgenic perspective publication-title: Diabetologia – volume: 270 start-page: 22565 year: 1995 end-page: 22570 ident: CR11 article-title: Identification of a new acute phase protein publication-title: J Biol Chem doi: 10.1074/jbc.270.38.22565 – volume: 276 start-page: 42077 year: 2001 end-page: 42083 ident: CR17 article-title: Hyperglycemia-induced production of acute phase reactants in adipose tissue publication-title: J Biol Chem doi: 10.1074/jbc.M107101200 – volume: 280 start-page: E827 year: 2001 end-page: E847 ident: CR32 article-title: The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation publication-title: Am J Physiol Endocrinol Metab – volume: 56 start-page: 2533 year: 2007 end-page: 2540 ident: CR13 article-title: The adipokine lipocalin 2 is regulated by obesity and promotes insulin resistance publication-title: Diabetes doi: 10.2337/db07-0007 – volume: 7 start-page: 779 year: 2007 end-page: 788 ident: CR18 article-title: Lipocalin-2 regulates the inflammatory response during ischemia and reperfusion of the transplanted heart publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2006.01723.x – volume: 18 start-page: 215 year: 2004 end-page: 217 ident: CR27 article-title: Gene expression profile of omental adipose tissue in human obesity publication-title: FASEB J – volume: 68 start-page: 213 year: 2008 end-page: 219 ident: CR29 article-title: Expression of caveolin-1 in human adipose tissue is upregulated in obesity and obesity-associated type 2 diabetes mellitus and related to inflammation publication-title: Clin Endocrinol – volume: 83 start-page: 461S year: 2006 end-page: 465S ident: CR21 article-title: Obesity and the role of adipose tissue in inflammation and metabolism publication-title: Am J Clin Nutr – volume: 69 start-page: 208 year: 2008 end-page: 215 ident: CR35 article-title: Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2007.03156.x – volume: 47 start-page: 1384 year: 1998 end-page: 1391 ident: CR38 article-title: Depot-related gene expression in human subcutaneous and omental adipocytes publication-title: Diabetes doi: 10.2337/diabetes.47.9.1384 – volume: 92 start-page: 3719 year: 2007 end-page: 3727 ident: CR45 article-title: Plasma osteopontin levels and expression in adipose tissue are increased in obesity publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0349 – volume: 106 start-page: 103 year: 2009 end-page: 108 ident: CR19 article-title: Lipocalin-2 is induced by interleukin-1β in murine adipocytes in vitro publication-title: J Cell Biochem doi: 10.1002/jcb.21980 – volume: 17 start-page: 1464 year: 2007 end-page: 1474 ident: CR26 article-title: Proinflammatory cytokines in obesity: impact of type 2 diabetes mellitus and gastric bypass publication-title: Obes Surg doi: 10.1007/s11695-008-9424-z – volume: 200 start-page: 448 year: 2003 end-page: 464 ident: CR22 article-title: Extracellular matrix remodeling: the role of matrix metalloproteinases publication-title: J Pathol doi: 10.1002/path.1400 – volume: 99 start-page: 290 year: 2008 end-page: 294 ident: CR41 article-title: Role of proteolysis in development of murine adipose tissue publication-title: Thromb Haemost – volume: 444 start-page: 875 year: 2006 end-page: 880 ident: CR5 article-title: Mechanisms linking obesity with cardiovascular disease publication-title: Nature doi: 10.1038/nature05487 – volume: 432 start-page: 917 year: 2004 end-page: 921 ident: CR8 article-title: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron publication-title: Nature doi: 10.1038/nature03104 – volume: 50 start-page: 2080 year: 2001 end-page: 2086 ident: CR23 article-title: Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation publication-title: Diabetes doi: 10.2337/diabetes.50.9.2080 – volume: 259 start-page: 87 year: 1993 end-page: 91 ident: CR46 article-title: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance publication-title: Science doi: 10.1126/science.7678183 – volume: 5 start-page: 323 year: 2007 end-page: 325 ident: CR6 article-title: Targeting fat to prevent diabetes publication-title: Cell Metab doi: 10.1016/j.cmet.2007.04.006 – volume: 456 start-page: 1 year: 2008 end-page: 22 ident: CR7 article-title: Overview of adipose tissue and its role in obesity and metabolic disorders publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-245-8_1 – volume: 74 start-page: 413 year: 1996 end-page: 417 ident: CR31 article-title: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma publication-title: Br J Cancer – volume: 436 start-page: 356 year: 2005 end-page: 362 ident: CR34 article-title: Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes publication-title: Nature doi: 10.1038/nature03711 – volume: 132 start-page: 2103 year: 2007 end-page: 2115 ident: CR1 article-title: The adipocyte as an active participant in energy balance and metabolism publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.058 – volume: 314 start-page: 386 year: 1992 end-page: 388 ident: CR10 article-title: A 25 kDa α 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase publication-title: FEBS Lett doi: 10.1016/0014-5793(92)81511-J – volume: 39 start-page: 495 year: 2007 end-page: 500 ident: CR28 article-title: Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus publication-title: Horm Metab Res doi: 10.1055/s-2007-982502 – volume: 276 start-page: 44926 year: 2001 end-page: 44935 ident: CR44 article-title: Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-κ B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells publication-title: J Biol Chem doi: 10.1074/jbc.M103334200 – volume: 293 start-page: 829 year: 2001 end-page: 834 ident: CR16 article-title: Induction of apoptosis by a secreted lipocalin that is transcriptionally regulated by IL-3 deprivation publication-title: Science doi: 10.1126/science.1061075 – volume: 276 start-page: 37258 year: 2001 end-page: 37265 ident: CR24 article-title: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL publication-title: J Biol Chem doi: 10.1074/jbc.M106089200 – volume: 13 start-page: 2169 year: 2007 end-page: 2175 ident: CR39 article-title: Visceral and subcutaneous adiposity: are both potential therapeutic targets for tackling the metabolic syndrome? publication-title: Curr Pharm Des doi: 10.2174/138161207781039599 – volume: 53 start-page: 34 year: 2007 end-page: 41 ident: CR12 article-title: Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans publication-title: Clin Chem doi: 10.1373/clinchem.2006.075614 – volume: 123 start-page: 1293 year: 2005 end-page: 1305 ident: CR9 article-title: A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake publication-title: Cell doi: 10.1016/j.cell.2005.10.027 – volume: 16 start-page: 79 year: 2006 end-page: 87 ident: CR42 article-title: Osteopontin: role in cell signaling and cancer progression publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2005.12.005 – volume: 579 start-page: 773 year: 2005 end-page: 777 ident: CR40 article-title: The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake publication-title: FEBS Lett doi: 10.1016/j.febslet.2004.12.031 – volume: 56 start-page: 2533 year: 2007 ident: 486_CR13 publication-title: Diabetes doi: 10.2337/db07-0007 – volume: 57 start-page: 1005 year: 2008 ident: 486_CR33 publication-title: Metabolism doi: 10.1016/j.metabol.2008.02.019 – volume: 83 start-page: 461S year: 2006 ident: 486_CR21 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/83.2.461S – volume: 259 start-page: 87 year: 1993 ident: 486_CR46 publication-title: Science doi: 10.1126/science.7678183 – volume: 8 start-page: 41 issue: Suppl 1 year: 2007 ident: 486_CR4 publication-title: Obes Rev doi: 10.1111/j.1467-789X.2007.00316.x – volume: 47 start-page: 1384 year: 1998 ident: 486_CR38 publication-title: Diabetes doi: 10.2337/diabetes.47.9.1384 – volume: 276 start-page: 37258 year: 2001 ident: 486_CR24 publication-title: J Biol Chem doi: 10.1074/jbc.M106089200 – volume: 68 start-page: 213 year: 2008 ident: 486_CR29 publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2007.03021.x – volume: 270 start-page: 22565 year: 1995 ident: 486_CR11 publication-title: J Biol Chem doi: 10.1074/jbc.270.38.22565 – volume: 200 start-page: 448 year: 2003 ident: 486_CR22 publication-title: J Pathol doi: 10.1002/path.1400 – volume: 579 start-page: 773 year: 2005 ident: 486_CR40 publication-title: FEBS Lett doi: 10.1016/j.febslet.2004.12.031 – volume: 132 start-page: 2103 year: 2007 ident: 486_CR1 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.058 – volume: 132 start-page: 2169 year: 2007 ident: 486_CR20 publication-title: Gastroenterology doi: 10.1053/j.gastro.2007.03.059 – volume: 74 start-page: 413 year: 1996 ident: 486_CR31 publication-title: Br J Cancer doi: 10.1038/bjc.1996.374 – volume: 34 start-page: 616 year: 2002 ident: 486_CR36 publication-title: Horm Metab Res doi: 10.1055/s-2002-38256 – volume: 16 start-page: 79 year: 2006 ident: 486_CR42 publication-title: Trends Cell Biol doi: 10.1016/j.tcb.2005.12.005 – volume: 69 start-page: 208 year: 2008 ident: 486_CR35 publication-title: Clin Endocrinol doi: 10.1111/j.1365-2265.2007.03156.x – volume: 13 start-page: 1232 year: 2005 ident: 486_CR25 publication-title: Obes Res doi: 10.1038/oby.2005.146 – volume: 39 start-page: 495 year: 2007 ident: 486_CR28 publication-title: Horm Metab Res doi: 10.1055/s-2007-982502 – volume: 7 start-page: 779 year: 2007 ident: 486_CR18 publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2006.01723.x – volume: 106 start-page: 103 year: 2009 ident: 486_CR19 publication-title: J Cell Biochem doi: 10.1002/jcb.21980 – volume: 314 start-page: 386 year: 1992 ident: 486_CR10 publication-title: FEBS Lett doi: 10.1016/0014-5793(92)81511-J – volume: 276 start-page: 42077 year: 2001 ident: 486_CR17 publication-title: J Biol Chem doi: 10.1074/jbc.M107101200 – volume: 46 start-page: 143 year: 2003 ident: 486_CR3 publication-title: Diabetologia doi: 10.1007/s00125-003-1053-4 – volume: 50 start-page: 2080 year: 2001 ident: 486_CR23 publication-title: Diabetes doi: 10.2337/diabetes.50.9.2080 – volume: 24 start-page: 1589 year: 2006 ident: 486_CR30 publication-title: J Hypertens doi: 10.1097/01.hjh.0000239295.17636.6e – volume: 92 start-page: 3719 year: 2007 ident: 486_CR45 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0349 – volume: 32 start-page: 129 year: 2009 ident: 486_CR15 publication-title: Diabetes Care doi: 10.2337/dc08-1236 – volume: 18 start-page: 215 year: 2004 ident: 486_CR27 publication-title: FASEB J doi: 10.1096/fj.03-0591fje – volume: 98 start-page: 1479 year: 2006 ident: 486_CR43 publication-title: Circ Res doi: 10.1161/01.RES.0000227550.00426.60 – volume: 15 start-page: 1996 year: 2001 ident: 486_CR2 publication-title: FASEB J doi: 10.1096/fj.00-0829hyp – volume: 456 start-page: 1 year: 2008 ident: 486_CR7 publication-title: Methods Mol Biol doi: 10.1007/978-1-59745-245-8_1 – volume: 276 start-page: 44926 year: 2001 ident: 486_CR44 publication-title: J Biol Chem doi: 10.1074/jbc.M103334200 – volume: 115 start-page: 610 year: 2005 ident: 486_CR47 publication-title: J Clin Invest doi: 10.1172/JCI23056 – volume: 5 start-page: 323 year: 2007 ident: 486_CR6 publication-title: Cell Metab doi: 10.1016/j.cmet.2007.04.006 – volume: 436 start-page: 356 year: 2005 ident: 486_CR34 publication-title: Nature doi: 10.1038/nature03711 – volume: 13 start-page: 2169 year: 2007 ident: 486_CR39 publication-title: Curr Pharm Des doi: 10.2174/138161207781039599 – volume: 53 start-page: 34 year: 2007 ident: 486_CR12 publication-title: Clin Chem doi: 10.1373/clinchem.2006.075614 – volume: 293 start-page: 829 year: 2001 ident: 486_CR16 publication-title: Science doi: 10.1126/science.1061075 – volume: 444 start-page: 875 year: 2006 ident: 486_CR5 publication-title: Nature doi: 10.1038/nature05487 – volume: 99 start-page: 290 year: 2008 ident: 486_CR41 publication-title: Thromb Haemost doi: 10.1160/TH07-10-0589 – volume: 17 start-page: 1464 year: 2007 ident: 486_CR26 publication-title: Obes Surg doi: 10.1007/s11695-008-9424-z – volume: 22 start-page: 1416 year: 2008 ident: 486_CR14 publication-title: Mol Endocrinol doi: 10.1210/me.2007-0420 – volume: 432 start-page: 917 year: 2004 ident: 486_CR8 publication-title: Nature doi: 10.1038/nature03104 – volume: 280 start-page: E827 year: 2001 ident: 486_CR32 publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.2001.280.6.E827 – volume: 123 start-page: 1293 year: 2005 ident: 486_CR9 publication-title: Cell doi: 10.1016/j.cell.2005.10.027 – volume: 444 start-page: 881 year: 2006 ident: 486_CR37 publication-title: Nature doi: 10.1038/nature05488 – reference: 18219773 - Obes Surg. 2007 Nov;17(11):1464-74 – reference: 16034410 - Nature. 2005 Jul 21;436(7049):356-62 – reference: 18292240 - Mol Endocrinol. 2008 Jun;22(6):1416-26 – reference: 11486081 - Science. 2001 Aug 3;293(5531):829-34 – reference: 17498506 - Gastroenterology. 2007 May;132(6):2103-15 – reference: 11564733 - J Biol Chem. 2001 Nov 30;276(48):44926-35 – reference: 16076993 - Obes Res. 2005 Jul;13(7):1232-7 – reference: 12845612 - J Pathol. 2003 Jul;200(4):448-64 – reference: 11522674 - Diabetes. 2001 Sep;50(9):2080-6 – reference: 18852336 - Diabetes Care. 2009 Jan;32(1):129-31 – reference: 11546817 - J Biol Chem. 2001 Nov 9;276(45):42077-83 – reference: 9726225 - Diabetes. 1998 Sep;47(9):1384-91 – reference: 17040956 - Clin Chem. 2007 Jan;53(1):34-41 – reference: 11350765 - Am J Physiol Endocrinol Metab. 2001 Jun;280(6):E827-47 – reference: 16470013 - Am J Clin Nutr. 2006 Feb;83(2):461S-465S – reference: 16406521 - Trends Cell Biol. 2006 Feb;16(2):79-87 – reference: 15670845 - FEBS Lett. 2005 Jan 31;579(3):773-7 – reference: 16709900 - Circ Res. 2006 Jun 23;98(12):1479-89 – reference: 14630696 - FASEB J. 2004 Jan;18(1):215-7 – reference: 12627314 - Diabetologia. 2003 Feb;46(2):143-72 – reference: 18081728 - Clin Endocrinol (Oxf). 2008 Aug;69(2):208-15 – reference: 18516549 - Methods Mol Biol. 2008;456:1-22 – reference: 17167477 - Nature. 2006 Dec 14;444(7121):881-7 – reference: 12660870 - Horm Metab Res. 2002 Nov-Dec;34(11-12):616-21 – reference: 17611901 - Horm Metab Res. 2007 Jul;39(7):495-500 – reference: 11486009 - J Biol Chem. 2001 Oct 5;276(40):37258-65 – reference: 17639021 - Diabetes. 2007 Oct;56(10 ):2533-40 – reference: 16377569 - Cell. 2005 Dec 29;123(7):1293-305 – reference: 17316300 - Obes Rev. 2007 Mar;8 Suppl 1:41-4 – reference: 17803693 - Clin Endocrinol (Oxf). 2008 Feb;68(2):213-9 – reference: 17498510 - Gastroenterology. 2007 May;132(6):2169-80 – reference: 1281792 - FEBS Lett. 1992 Dec 21;314(3):386-8 – reference: 17627548 - Curr Pharm Des. 2007;13(21):2169-75 – reference: 17488634 - Cell Metab. 2007 May;5(5):323-5 – reference: 8695357 - Br J Cancer. 1996 Aug;74(3):413-7 – reference: 17595250 - J Clin Endocrinol Metab. 2007 Sep;92(9):3719-27 – reference: 11532980 - FASEB J. 2001 Sep;15(11):1996-2006 – reference: 17391123 - Am J Transplant. 2007 Apr;7(4):779-88 – reference: 18555844 - Metabolism. 2008 Jul;57(7):1005-15 – reference: 7678183 - Science. 1993 Jan 1;259(5091):87-91 – reference: 16877962 - J Hypertens. 2006 Aug;24(8):1589-97 – reference: 19009554 - J Cell Biochem. 2009 Jan 1;106(1):103-8 – reference: 17167476 - Nature. 2006 Dec 14;444(7121):875-80 – reference: 15711640 - J Clin Invest. 2005 Mar;115(3):610-21 – reference: 18278177 - Thromb Haemost. 2008 Feb;99(2):290-4 – reference: 15531878 - Nature. 2004 Dec 16;432(7019):917-21 – reference: 7545679 - J Biol Chem. 1995 Sep 22;270(38):22565-70 |
SSID | ssj0017594 |
Score | 2.3612156 |
Snippet | Lipocalin-2 (LCN2) is a novel adipokine with potential roles in obesity, insulin resistance, and inflammation. The aim of the present work was to evaluate the... |
SourceID | proquest pubmed pascalfrancis crossref springer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 803 |
SubjectTerms | Acute-Phase Proteins - genetics Acute-Phase Proteins - metabolism Adult Antigens, CD - genetics Antigens, CD - metabolism Antigens, Differentiation, Myelomonocytic - genetics Antigens, Differentiation, Myelomonocytic - metabolism Biological and medical sciences Biomedical and Life Sciences Biomedicine Body fat Female Gene Expression Regulation General aspects Human Genetics Humans Internal Medicine Intra-Abdominal Fat - metabolism Lipocalin-2 Lipocalins - blood Lipocalins - genetics Lipocalins - metabolism Male Matrix Metalloproteinase 2 - blood Matrix Metalloproteinase 2 - genetics Matrix Metalloproteinase 2 - metabolism Matrix Metalloproteinase 9 - blood Matrix Metalloproteinase 9 - genetics Matrix Metalloproteinase 9 - metabolism Medical sciences Metabolic diseases Molecular Medicine Obesity Obesity - genetics Obesity - metabolism Obesity - physiopathology Original Article Osteopontin - genetics Osteopontin - metabolism Protein Binding Proto-Oncogene Proteins - blood Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins - metabolism RNA, Messenger - genetics Tumor Necrosis Factor-alpha - genetics Tumor Necrosis Factor-alpha - metabolism |
SummonAdditionalLinks | – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Lat0wEB3aFEqhlKZPN02qRVctAluybGkZSkMIJKteyM7oCYbEvsROyQf1QzuSHyEkKXThjUeyZM_InvHRnAH46lVQOXM5BjlC0tIWJZW68LTQuUPvXwTj4n_I07PqeFOenIvzOY97WHa7L5BkelOvyW4JxaHTz3xZUfkUnokYuqMRb9jhCh3UIlU_xLClogyjgQXKfOgSdz5GL7d6wOcSpoIWD3mc99DS9BE6eg2vZu-RHE7q3oUnvnsDz09nfPwt_MHlHneZe0e0a7f94MmYnizxN_OO1470gVygDCfRdpSRFs9M1QFIO5CU24Ldxx4FAc1lSm0kunPkMtL535BLP0a0PjE8tB0OhhdJ4nvnFYlpE78TaWscJxUEHN7B5ujnrx_HdK7DQG2pqpFqI6xlvLJKCl9Yw5VTdcg50_iCEN4Zm3tXGzQHqY1F_zDnSlhfWuWCC4Xn72Gn6zv_EUilhJQFLwwLrOSWa-uMRK8IO3LuZJFBviiksTNJeayVcdGs9MpJh00eD9RhIzP4tnbZTgwd_2p8cEfLaw8WiTKVqjPYW9TezKt5SEKJcTPP4MsqxWUYsRXd-f4am0QSHnS9H29R1WVVojeUwYfJmm5nGzn-0XHM4PtiXrdjP3orn_6r9R68mHCwuHXxM-yMV9d-H92p0Ryk5fMXMa0Z1Q priority: 102 providerName: Springer Nature |
Title | Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans |
URI | https://link.springer.com/article/10.1007/s00109-009-0486-8 https://www.ncbi.nlm.nih.gov/pubmed/19466389 https://www.proquest.com/docview/217684463 https://www.proquest.com/docview/20146020 https://www.proquest.com/docview/67464661 |
Volume | 87 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3daxQxEA_agggifrtWzzz4pAQ3m91s8iSnXC1Ki4gH59OSTbKw0O6e3W3pH-Qf6kz2o5TaPhwH-bjkdibJb3YmvyHkndeVjhMXg5GTKZZanjJluGfcxA7Qf1aVDt9DHh7Jg3X6bZNtxticbgyrnPbEsFG71uI78o8AnaUC20V82v5hmDQKnatjBo27ZBeZyzCiK9_M9hYcjCEPIhgwkiVgF0xOzThwiHL0CgTPgJJMXTmWHmxNB0-oGlJb_A97XvObhuNo_xF5OOJIuhwE_5jc8c0Tcu9w9JQ_JX9h4WO8uXfUuHrbdp724RlTfzHGvja0regx1MEk6oYltIaSIU8ArTsabrlA976FigoUZ7jkSE3j6AkS-1_QE9-j3z5wPdQNDAY_EqqvlWuKFyjOA30rjhNSA3bPyHp_9evLARszMjCbatkzU2bWJkJarTLPbSm003kVi8TAVpF5V9rYu7wExVCmtIAUY6Ez61OrXeUq7sVzstO0jX9JqAR5KS54mVRJKqww1pUK8BF0FMIpHpF4EkhhR7pyzJpxXMxEy0GGRYwfkGGhIvJ-7rIduDpua7y4IuW5Byqa1DqPyN4k9mJc110xa2FE3s61sCDRy2Ia355BE6TjARB-cwuZpzIFXBSRF4M2Xc4W2f4BQkbkw6Rel2Pf-Fde3TrTPXJ_8IBh0OJrstOfnvk3AKT6chGWy4LsLr_-_r6C78-rox8_oXSdLP8BSsohAw |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRICPEmFFof4AKySOLEax8Q4tFqS7srhFqpt9SxHSlSmywkhfJ_uPIfGTuPqirtrYdcYjt2NJPJN57xfAAvrSxkGJsQnZxU0ERHCRUqsjRSoUH0nxa5cfuQ8wWf7SdfDtKDFfg7nIVxaZWDTfSG2tTa7ZG_RejMBfou7P3yO3WkUS64OjBodFqxY3__Qo-tebf9GcX7Ko63Nvc-zWhPKkB1InlLVZ5qHTOupUhtpHMmjZwWIYsVantqTa5Da6Y5vptQuUawEzKZaptoaQpTRJbhc2_AasLQk5nA6sfNxddvY9himnrmRXSZOI3RExnCqKGvWhq5OISPRQhOxbkf4Z2lalAmRUem8T-0eyFS63-AW_fgbo9cyYdO1e7Diq0ewM15H5t_CH_Q1LgMd2uIMuWybixpvVSJPe2zbStSF-QI23ARZUVjUuKdjpmAlA3x52pweFtjQ4Gq2h2rJKoy5NhRCZySY9u6TAFfXaKscDJ8iG--cF8Sd2Tjpy8Y6-bxZITNI9i_FnE9hklVV_YpEC5TISIW5XERJ0wzpU0uEJHhQMaMiAIIB4Fkui-Q7ng6jrKxtLOXYRa6C2WYiQBej0OWXXWQqzqvn5PyOMKpNpdyGsDaIPastyRNNup9ABtjK5oAF9dRla1PsIsrAISw__IefJrwBJFYAE86bTpbreMXQNAawJtBvc7mvvRVnl250g24Ndub72a724udNbjdxd9cyuRzmLQ_TuwLhHFtvt5_PAQOr_t7_QcOgl4B |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jb9UwEB6VIlVICLGWUGh9gAvIahxnsQ8IIcpTS2nFgUrvFhwv0pPa5EFSKP-HP8G_Y-wsVVXaWw-5xHbsaBbPeMbzAby00sk4MTE6OZmgqWYpFYpZylRs0PrPXGX8OeTBYb57lH6aZ_MV-DvehfFplaNODIraNNqfkW-j6ZwL9F34thuyIr7szN4tv1MPIOUDrSOaRs8h-_b3L_Te2rd7O0jqV0ky-_j1wy4dAAaoTmXeUVVlWic811JklumKSyMLF_NEIedn1lQ6tqao8D-FqjQaPjGXmbaplsYZxyzH796C2wXPmBexYj75ergpBwxGdJ5ymqBPMgZU41C_lPmIRIhKiJyKC1vi3aVqkTquh9X4n917KWYbtsLZfbg32LDkfc90D2DF1g9h7WCI0j-CP6h0fK67NUSZxbJpLekCfYk9G_Jua9I4coxtuIhFTROywDc9RgFZtCTcsMHhXYMNDpm2v2BJVG3IiQcVOCMntvM5A6HOxKLGyfAjofnSe0n85Y2foXSsnyfAEraP4ehGiPUEVuumtk-B5DITgnFWJS5JueZKm0qgbYYDOTeCRRCPBCn1UCrdI3Ycl1OR50DDMvYP0rAUEbyehiz7OiHXdd68QOVphGfyXMoigo2R7OWgU9pykoAItqZWVAY-wqNq25xiF18KCB2Aq3vkRZqnaJNFsN5z0_lqPdIAmq8RvBnZ63zuK3_l2bUr3YI1lNLy897h_gbc6QNxPnfyOax2P07tC7TnumozSA6Bbzctqv8ARsFg0Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+adipose+tissue+expression+of+lipocalin-2+in+obesity+is+related+to+inflammation+and+matrix+metalloproteinase-2+and+metalloproteinase-9+activities+in+humans&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Catal%C3%A1n%2C+V&rft.au=G%C3%B3mez-Ambrosi%2C+J&rft.au=Rodr%C3%ADguez%2C+A&rft.au=Ram%C3%ADrez%2C+B&rft.date=2009-08-01&rft.eissn=1432-1440&rft.volume=87&rft.issue=8&rft.spage=803&rft.epage=813&rft_id=info:doi/10.1007%2Fs00109-009-0486-8&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon |